Our research is focused on the synthesis, photochemistry and bio-activity of coordination or organometallic compounds employing a platinum group transition metal centre, most commonly ruthenium(II), bound to organic ligands.

 

These compounds are of great interest in chemical biology and medicinal chemistry as they have coordination numbers greater than carbon’s limit of 4, well-developed synthetic pathways, extremely useful photochemical properties for assay development and possess at least one metal atom identifiable by mass spectrometry.

 

Our aim is to develop these molecules for use as cell imaging agents, tools for molecular biology and therapeutic leads, particular within cancer research. 

​

See PROJECTS for more about our current research strands.